Amylin family peptides and methods for making and using them

Details for Australian Patent Application No. 2005320351 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Ghosh, Soumitra; Parkes, David Geoffrey; Lin, Qing; Hanley, Michael R.; Prickett, Kathryn S.; Jodka, Carolyn Marie; Mack, Christine Marie; Lewis, Diana Yvonne; Soares, Christopher J.

Agent Freehills

Pub. Number AU-B-2005320351

PCT Pub. Number WO2006/083254

Priority 60/550,447 04.03.04 US; 60/543,275 11.02.04 US

Filing date 11 February 2005

Wipo publication date 31 August 2006

Acceptance publication date 3 June 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

31 August 2006 Application Open to Public Inspection

  Published as AU-B-2005320351

31 August 2006 PCT application entered the National Phase

  PCT publication WO2006/083254 Priority application(s): WO2006/083254

18 December 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Name Amylin Pharmaceuticals, Inc., Application No. 2005320351, under INID (43), correct the date to 10 August 2006 Corrigenda

3 June 2010 Application Accepted

  Published as AU-B-2005320351

30 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005320352-Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer

2005320350-Ozone injection method and system